A randomized trial of cytarabine with high-dose mitoxantrone compared to a standard vincristine/prednisone-based regimen as induction therapy for adult patients with ALL.

被引：0
|
作者：
Weiss, MA
Heffner, L
Lamanna, N
Kalaycio, M
Schiller, G
Coutre, S
Maslak, P
Jurcic, J
Panageas, K
Scheinberg, DA
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Emory Univ, Atlanta, GA 30322 USA
[3] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[4] Univ Calif Los Angeles, Los Angeles, CA USA
[5] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：564S / 564S
页数：1
相关论文
共 50 条
  • [11] A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia
    Weiss, MA
    Drullinsky, P
    Maslak, P
    Scheinberg, D
    Golde, DW
    LEUKEMIA, 1998, 12 (06) : 865 - 868
  • [12] A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia
    MA Weiss
    P Drullinsky
    P Maslak
    D Scheinberg
    DW Golde
    Leukemia, 1998, 12 : 865 - 868
  • [13] High Dose Cytarabine and Mitoxantrone in Combination with Dasatinib As Active Induction Therapy in Adult Patients with Philadelphia Chromosome Positive (ph plus ) Acute Lymphoblastic Leukemia (ALL)
    Lamanna, Nicole
    Weiss, Mark
    Berman, Ellin
    Frattini, Mark G.
    Heaney, Mark
    Jurcic, Joseph G.
    Rosenblat, Todd L.
    Landau, Heather
    Weissbrot, Hanna
    Maslak, Peter G.
    BLOOD, 2012, 120 (21)
  • [14] A randomized trial of high- versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine
    Bradstock, KF
    Matthews, JP
    Lowenthal, RM
    Baxter, H
    Catalano, J
    Brighton, T
    Gill, D
    Eliadis, P
    Joshua, D
    Cannell, P
    Schwarer, AP
    Durrant, S
    Gillett, A
    Koutts, J
    Taylor, K
    Bashford, J
    Arthur, C
    Enno, A
    Dunlop, L
    Szer, J
    Leahy, M
    Juneja, S
    Young, GAR
    BLOOD, 2005, 105 (02) : 481 - 488
  • [15] Post remission therapy in older patients with de novo acute myeloid leukemia (AML): A randomized trial of mitoxantrone/intermediate dose cytarabine 'V' standard dose cytarabine (CALBG 8923).
    Stone, RM
    Berg, DT
    George, SL
    Dodge, RK
    Paciucci, PA
    Schulman, P
    Lee, EJ
    Moore, JO
    Powell, BL
    Schiffer, CA
    BLOOD, 1997, 90 (10) : 2255 - 2255
  • [16] A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia
    Lee, Je-Hwan
    Joo, Young-Don
    Kim, Hawk
    Bae, Sung Hwa
    Kim, Min Kyoung
    Zang, Dae Young
    Lee, Jung-Lim
    Lee, Gyeong Won
    Lee, Jung-Hee
    Park, Jae-Hoo
    Kim, Dae-Young
    Lee, Won-Sik
    Ryoo, Hun Mo
    Hyun, Myung Soo
    Kim, Hyo Jung
    Min, Young Joo
    Jang, Yae-Eun
    Lee, Kyoo-Hyung
    BLOOD, 2011, 118 (14) : 3832 - 3841
  • [17] Should induction therapy with high-dose glucocorticoids be the standard treatment for all patients with giant cell arteritis?
    Carol A Langford
    Gary S Hoffman
    Nature Clinical Practice Rheumatology, 2007, 3 : 132 - 133
  • [18] Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy
    Huetter-Kroenke, Marie-Luise
    Benner, Axel
    Doehner, Konstanze
    Krauter, Juergen
    Weber, Daniela
    Moessner, Margit
    Koehne, Claus-Henning
    Horst, Heinz A.
    Schmidt-Wolf, Ingo G. H.
    Rummel, Mathias
    Goetze, Katharina
    Koller, Elisabeth
    Petzer, Andreas L.
    Salwender, Hans
    Fiedler, Walter
    Kirchen, Heinz
    Haase, Detlef
    Kremers, Stephan
    Theobald, Matthias
    Matzdorff, Axel C.
    Ganser, Arnold
    Doehner, Hartmut
    Schlenk, Richard F.
    HAEMATOLOGICA, 2016, 101 (07) : 839 - 845
  • [19] Faster platelet recovery by high-dose dexamethasone compared with standard-dose prednisolone in adult immune thrombocytopenia: a prospective randomized trial
    Praituan, W.
    Rojnuckarin, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (06) : 1036 - 1038
  • [20] Should induction therapy with high-dose glucocorticoids be the standard treatment for all patients with giant cell arteritis? Commentary
    Langford, Carol A.
    Hoffman, Gary S.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (03): : 132 - 133
12345